# Litfulo

NDC: 0069-0334
Generic name: ritlecitinib
Labeler / Manufacturer: Pfizer Laboratories Div Pfizer Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20230706

FDA application: NDA215830

## Active ingredients

- RITLECITINIB TOSYLATE: 50 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0069-0334"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0069-0334
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6b2f9446-fb23-4741-b73a-5a2f993733c3